Company intelligence / Profile preview

New Mountain Capital

New York City, New York, United Statesnewmountaincapital.com ↗

Ownership: Private
Development stage: Other

Overview

New Mountain Capital is an alternative investment management firm with approximately $55 billion in assets under management as of 2024. The company focuses on private equity, credit, and net lease strategies with an emphasis on business building and growth in economically acyclical industries. It is known for investing in sectors such as healthcare/health tech, life science supplies/biomanufacturing, software/data services, and more. While it is not itself a biotech or pharma company, it owns and operates several healthcare/life sciences businesses through its portfolio[1][2][3][5].

Industry: Investors

Beyond the preview

Go deeper on New Mountain Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Mountain Capital.

Explore the full profile